Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
arrowhead pharmaceuticals
biotech
boston blog main
boston top stories
clinical trials
deals
2
×
eli lilly
indiana blog main
indiana top stories
life sciences
national blog main
national top stories
rna interference
san francisco blog main
san francisco top stories
wisconsin blog main
wisconsin top stories
a2 biotherapeutics
aduro biotech
agency
akili interactive labs
alexion pharmaceuticals
alicia hager
alnylam pharmaceutials
alpha-1 antitrypsin
alzheimer's disease
amag pharmaceuticals
amgen
arca biopharma
arch venture partners
axovant gene therapies
bacteriophage
biogen
biontech
biotech ipos
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
bridgebio
What
rnai
2
×
abandoning
ago
alliance
baggage
bio
bristol
buy
calls
changing
color
companies
crispr
cuts
days
deal
development
dicerna
free
gets
growing
hours
interference
kudos
leaves
long
medicines
myers’s
notifying
october
pharma
phone
rna
roundup
rouse
scientists
shorter
signs
slumber
small
Language
unset
Current search:
rnai
×
deals
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M